Conjugated vaccine against meningococcus C

Authors

  • Divisão de Imunização Centro de Vigilância Epidemiológica
  • Divisão de Doenças de Transmissão Respiratórias Centro de Vigilância Epidemiológica

Abstract

 

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de Vigilância Epidemiológica. 7º edição - Cad. 12 pg. 32– Meningites. Departamento de Vigilância Epidemiológica – Brasília (DF); 2009.

Ministério da Saúde. Secretaria de Vigilância em Saúde. Introdução da vacina meningocócica C (conjugada) no calendário de vacinação da criança. Departamento de Vigilância Epidemiológica – Brasília (DF); 2010:1-18.

Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clinical Microbiology Reviews; 2006:142-64.

Trotter CL, Borrow R, Findlow J, Holland A, Frankland S, Andrews NJ, Miller E. Seroprevalence of antibodies against serogrup C meningococci in England in the posvaccination era. Clinical and vaccine immunology; 2008:1694-8.

Laurrari A, Cano R, García M, Mateo S. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Vaccine. 2005;23(32):4097-100.

Borrow R, Miller E. Long-term protection in children with meningococcal C conjugate vaccination: lessons learned. Expert Rev Vaccines. 2006;5(6):851-7.

Campbell H, Borrow R, Salisbury D, Miller E. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine. 2009;27(Suppl 2):B20-9.

Snape MD, Kelly DF, Lewis S, Banner C, Kibwana L, Moore CE, Diggle L, John T, Yu LM, Borrow R, Borkowski A, Nau C, Pollard AJ. Seroprotection against serogrup C meningococcal disease in adolescents in United Kingdom: observational study; BMJ 2008; 336:1487-91.

Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococal serogroup C conjugate vaccine 4 years after introduction. Lancet, 2004; 364:365-7.

Sáfadi MA, Barros AP. Meningococcal conjugate vaccines: efficacy and new combinations. J Pediatr (RJ). 2006; 82(3 Suppl):S35-44.

Lakshman R,Jones I, Walker D, McMurtrie K, Shaw L, Race G, Choo S, Danzig L, Oster P, Finn A. Safety of new conjugate meningococcal C vaccine in infants, Arch Dis Child. 2001;85:391-7.

Southern J, Borrow R, Andrews N, Morris R, Waight P, Hudson M, et al. Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom. Clin Vaccine Immunol. 2009;16(2):194-9.

Published

2010-09-30

How to Cite

1.
Divisão de Imunização, Divisão de Doenças de Transmissão Respiratórias. Conjugated vaccine against meningococcus C. Bepa [Internet]. 2010 Sep. 30 [cited 2024 May 20];7(81):26-31. Available from: https://periodicos.saude.sp.gov.br/BEPA182/article/view/38488

Issue

Section

Technical Information

Most read articles by the same author(s)

<< < 1 2 3 > >>